242 related articles for article (PubMed ID: 18295951)
1. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Jantos H
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
Monti JM; Jantos H; Catenaccio V; Xavier S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
[TBL] [Abstract][Full Text] [Related]
3. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
Monti JM; Jantos H; Lagos P
Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
[TBL] [Abstract][Full Text] [Related]
4. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Leopoldo M; Jantos H
Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
[TBL] [Abstract][Full Text] [Related]
5. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
Monti JM; Jantos H; Monti D; Alvariño F
Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
[TBL] [Abstract][Full Text] [Related]
6. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
[TBL] [Abstract][Full Text] [Related]
7. Serotonin control of sleep-wake behavior.
Monti JM
Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
[TBL] [Abstract][Full Text] [Related]
8. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
Monti JM
Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
[TBL] [Abstract][Full Text] [Related]
9. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
[TBL] [Abstract][Full Text] [Related]
11. Central 5-HT3 receptor stimulation by m-CPBG increases blood glucose in rats.
Carvalho F; Macêdo D; Bandeira I; Maldonado I; Salles L; Azevedo MF; Rocha MA; Fregoneze JB; De Castro-e-Silva E
Horm Metab Res; 2002 Feb; 34(2):55-61. PubMed ID: 11972287
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
Oatway MA; Chen Y; Weaver LC
Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
[TBL] [Abstract][Full Text] [Related]
13. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
Monti JM; Jantos H; Monti D
Eur Neuropsychopharmacol; 2002 Feb; 12(1):47-55. PubMed ID: 11788240
[TBL] [Abstract][Full Text] [Related]
14. Increased extracellular 5-HT but no change in sleep after perfusion of a 5-HT1A antagonist into the dorsal raphe nucleus of rats.
Fiske E; Portas CM; Grønli J; Sørensen E; Bjorvatn B; Bjørkum AA; Ursin R
Acta Physiol (Oxf); 2008 May; 193(1):89-97. PubMed ID: 18081887
[TBL] [Abstract][Full Text] [Related]
15. Role of central 5-HT3 receptors in the control of blood pressure in stressed and non-stressed rats.
Ferreira HS; de Castro e Silva E; Cointeiro C; Oliveira E; Faustino TN; Fregoneze JB
Brain Res; 2004 Nov; 1028(1):48-58. PubMed ID: 15518641
[TBL] [Abstract][Full Text] [Related]
16. The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness.
Monti JM
Sleep Med Rev; 2010 Oct; 14(5):307-17. PubMed ID: 20153669
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
Monti JM; Jantos H
Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus.
Duncan MJ; Davis VA
Brain Res; 2005 Oct; 1058(1-2):10-6. PubMed ID: 16150426
[TBL] [Abstract][Full Text] [Related]
19. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
Monti JM; Leopoldo M; Jantos H; Lagos P
Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
[TBL] [Abstract][Full Text] [Related]
20. The nucleus raphe magnus suppresses vomiting, and the solitary nucleus and 5-HT are not involved in this suppression.
Hattori Y; Hamaguchi C; Yamada Y; Urayama Y; Nakamura E; Koga T; Fukuda H
Auton Neurosci; 2010 Jan; 152(1-2):41-8. PubMed ID: 19773202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
